AKEBIA THERAPEUTICS, INC. (AKBA) Operating margin 2016–2025
AKEBIA THERAPEUTICS, INC. (AKBA) operating margin by fiscal year — reported operating income divided by reported revenue.
9.9%FY2025 · since FY2016: -8889.9% → 9.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 9.9% | +41.5 pp |
| FY2024 | -31.5% | -7.7 pp |
| FY2023 | -23.8% | +3.9 pp |
| FY2022 | -27.6% | +97.4 pp |
| FY2021 | -125.0% | +3.3 pp |
| FY2020 | -128.2% | -42.8 pp |
| FY2019 | -85.5% | +0.3 pp |
| FY2018 | -85.8% | -43.5 pp |
| FY2017 | -42.3% | +8847.6 pp |
| FY2016 | -8889.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice